Does androgen-deprivation therapy for prostate cancer increase the risk for thromboembolic disease?

被引:0
|
作者
Pinthus, Jehonathan H. [1 ]
Duivenvoorden, Wilhelmina C. [1 ]
机构
[1] McMaster Univ, Div Urol, Dept Surg, Hamilton, ON, Canada
来源
关键词
VENOUS THROMBOEMBOLISM;
D O I
10.5489/cuaj.4394
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:39 / 40
页数:2
相关论文
共 50 条
  • [1] Androgen-deprivation Therapy and Risk for Biliary Disease in Men with Prostate Cancer
    Saylor, Philip J.
    Smith, Matthew R.
    O'Malley, A. James
    Keating, Nancy L.
    EUROPEAN UROLOGY, 2014, 65 (03) : 642 - 649
  • [2] Does Androgen Deprivation Therapy for Prostate Cancer Increase the Risk of Colorectal Cancer?
    Martling, Anna
    CANCER CONTROL, 2015, 22 (02) : 261 - 262
  • [3] Androgen-Deprivation Therapy and the Risk of Stroke in Patients With Prostate Cancer
    Azoulay, Laurent
    Yin, Hui
    Benayoun, Serge
    Renoux, Christel
    Boivin, Jean-Francois
    Suissa, Samy
    EUROPEAN UROLOGY, 2011, 60 (06) : 1244 - 1250
  • [4] Risk of thromboembolic disease in men with prostate cancer undergoing androgen deprivation therapy
    O'Farrell, Sean
    Sandstrom, Karin
    Garmo, Hans
    Stattin, Par
    Holmberg, Lars
    Adolfsson, Jan
    Van Hemelrijck, Mieke
    BJU INTERNATIONAL, 2016, 118 (03) : 391 - 398
  • [5] Timing of androgen-deprivation therapy in prostate cancer
    Nandagopal, Lakshminarayanan
    LANCET ONCOLOGY, 2017, 18 (11): : E634 - E634
  • [6] Insomnia and androgen-deprivation therapy for prostate cancer
    Savard, J.
    Ivers, H.
    Simard, S.
    PSYCHO-ONCOLOGY, 2007, 16 (09) : S150 - S151
  • [7] Risk and Timing of Cardiovascular Disease After Androgen-Deprivation Therapy in Men With Prostate Cancer
    O'Farrell, Sean
    Garmo, Hans
    Holmberg, Lars
    Adolfsson, Jan
    Stattin, Par
    Van Hemelrijck, Mieke
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (11) : 1243 - +
  • [8] Androgen-Deprivation Therapy and Cardiovascular Disease Risk - The Role of Exercise in prostate Cancer Treatment
    Wall, Bradley
    FRONTIERS IN ONCOLOGY, 2016, 6
  • [9] Biopsychosocial impact of prostate cancer and androgen-deprivation therapy
    Tripp, Dean A.
    Verreault, Phylicia
    Tong, Steven
    Izard, Jason
    Black, Angela
    Siemens, D. Robert
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2017, 11 (10): : 338 - 343
  • [10] Complications of androgen-deprivation therapy in men with prostate cancer
    Chen A.C.
    Petrylak D.P.
    Current Urology Reports, 2005, 6 (3) : 210 - 216